Molecular Therapeutics Research Participant Appreciation Eve
Adam Boxer, MD, PhD, Director of the Clinical Trials Program at USCF's Memory and Aging Center, discusses recent results from clinical trials and potential new molecular therapies for Alzheimers disease, frontotemporal dementia and other forms of dementia.
